Literature DB >> 31919771

Sonographic features of follicular variant of papillary thyroid carcinoma (FV-PTC) and diagnostic performance of the 2017 ACR TI-RADS in FV-PTC.

Fan Zhang1, Wen Chen2.   

Abstract

PURPOSE: To find the sonographic features of follicular variant of papillary thyroid carcinoma (FV-PTC) and evaluate the diagnostic performance of 2017 ACR TI-RADS in FV-PTC.
METHODS: From June 2017 to June 2019, 104 FV-PTC patients (106 nodules) and 337 classic papillary thyroid carcinoma (C-PTC) patients (343 nodules) with both sonograms and pathologic results were included. Sonographic features of FV-PTC and C-PTC were evaluated and compared, and 2017 ACR TI-RADS scores and levels were calculated.
RESULTS: Pathologically, the incidence of Hashimoto's thyroiditis and extrathyroidal extension was higher in the FV-PTC group. Most of both the FV-PTC and C-PTC groups were diagnosed as PTC or suspicious PTC by fine-needle aspiration biopsy (FNAB). FV-PTC tended to be isoechoic, while most nodules of C-PTC were hypoechoic or very hypoechoic. Compared with C-PTC, FV-PTC had lower percentages of a taller-than-wide shape (11.3% vs. 46.6%) and lobulated or irregular margin (33.0% vs. 61.8%), and a higher percentage of extrathyroidal extension (20.8% vs. 8.2%). FV-PTC featured macrocalcifications, whereas punctate echogenic foci were more frequently seen in the C-PTC group. Other characteristic US appearances of FV-PTC included uneven hypoechoic halo and peripheral vascularity. The mean TI-RADS score of FV-PTC cases was lower in the FV-PTC group, 11.3%, 44.3%, and 42.5% of which were categorized as TI-RADS 3, 4, and 5, respectively.
CONCLUSIONS: FV-PTC features isoechoic appearance, macrocalcifications, uneven hypoechoic halo, and peripheral vascularity on US, with lower incidences of microcalcifications and taller-than-wide shape, and tends to have lower TI-RADS scores and levels. For the nodules categorized as TI-RADS 3 or 4, the FNAB criteria should be broaden when these nodules have FV-PTC US features.

Entities:  

Keywords:  ACR Thyroid Imaging Reporting and Data System (ACR TI-RADS); Follicular variant of papillary thyroid carcinoma (FV-PTC); Ultrasound

Mesh:

Year:  2020        PMID: 31919771     DOI: 10.1007/s12020-019-02184-5

Source DB:  PubMed          Journal:  Endocrine        ISSN: 1355-008X            Impact factor:   3.633


  26 in total

1.  Classical and follicular variant papillary thyroid carcinoma: comparison of clinical, ultrasonographical, cytological, and histopathological features in 444 patients.

Authors:  Didem Ozdemir; Reyhan Ersoy; Neslihan Cuhaci; Dilek Arpaci; Eren P Ersoy; Birol Korukluoglu; Gulnur Guler; Bekir Cakir
Journal:  Endocr Pathol       Date:  2011-06       Impact factor: 3.943

2.  Comparison among TIRADS (ACR TI-RADS and KWAK- TI-RADS) and 2015 ATA Guidelines in the diagnostic efficiency of thyroid nodules.

Authors:  Luying Gao; Xuehua Xi; Yuxin Jiang; Xiao Yang; Ying Wang; Shenling Zhu; Xingjian Lai; Xiaoyan Zhang; Ruina Zhao; Bo Zhang
Journal:  Endocrine       Date:  2019-01-18       Impact factor: 3.633

Review 3.  What if many follicular variant papillary thyroid carcinomas are not malignant? A review of follicular variant papillary thyroid carcinoma and a proposal for a new classification.

Authors:  Gilbert H Daniels
Journal:  Endocr Pract       Date:  2011 Sep-Oct       Impact factor: 3.443

4.  Can New Ultrasound Signs Help in Identifying Follicular Variant of Papillary Carcinoma of Thyroid? - A Pilot Study.

Authors:  C Anuradha; M T Manipadam; H S Asha; N Dukhabandhu; D Abraham; M J Paul
Journal:  Ultrasound Int Open       Date:  2016-04-28

5.  Sonographic features of thyroid follicular carcinoma in comparison with thyroid follicular adenoma.

Authors:  Ji-Zhen Zhang; Bing Hu
Journal:  J Ultrasound Med       Date:  2014-02       Impact factor: 2.153

Review 6.  Thyroid Imaging Reporting and Data System (TI-RADS): A User's Guide.

Authors:  Franklin N Tessler; William D Middleton; Edward G Grant
Journal:  Radiology       Date:  2018-04       Impact factor: 11.105

7.  Follicular variant of thyroid papillary carcinoma: a clinicopathologic study of six cases.

Authors:  K T Chem; J Rosai
Journal:  Am J Surg Pathol       Date:  1977-06       Impact factor: 6.394

8.  Molecular Profile and Clinicopathologic Features of Follicular Variant Papillary Thyroid Carcinoma.

Authors:  Seo Young Sohn; Jeong-Ju Lee; Jae Hyuk Lee
Journal:  Pathol Oncol Res       Date:  2019-03-21       Impact factor: 3.201

9.  Differential Clinicopathological Risk and Prognosis of Major Papillary Thyroid Cancer Variants.

Authors:  Xiaoguang Shi; Rengyun Liu; Fulvio Basolo; Riccardo Giannini; Xiaopei Shen; Di Teng; Haixia Guan; Zhongyan Shan; Weiping Teng; Thomas J Musholt; Khawla Al-Kuraya; Laura Fugazzola; Carla Colombo; Electron Kebebew; Barbara Jarzab; Agnieszka Czarniecka; Bela Bendlova; Vlasta Sykorova; Manuel Sobrinho-Simões; Paula Soares; Young Kee Shong; Tae Yong Kim; Sonia Cheng; Sylvia L Asa; David Viola; Rossella Elisei; Linwah Yip; Caterina Mian; Federica Vianello; Yangang Wang; Shihua Zhao; Gisele Oler; Janete M Cerutti; Efisio Puxeddu; Shen Qu; Qing Wei; Huixiong Xu; Christine J O'Neill; Mark S Sywak; Roderick Clifton-Bligh; Alfred K Lam; Garcilaso Riesco-Eizaguirre; Pilar Santisteban; Hongyu Yu; Giovanni Tallini; Elizabeth H Holt; Vasily Vasko; Mingzhao Xing
Journal:  J Clin Endocrinol Metab       Date:  2015-11-03       Impact factor: 5.958

10.  Ultrasonographic Characteristics of the Follicular Variant Papillary Thyroid Cancer According to the Tumor Size.

Authors:  Eon Ju Jeon; Young Ju Jeong; Sung Hwan Park; Chang Ho Cho; Ho Sang Shon; Eui Dal Jung
Journal:  J Korean Med Sci       Date:  2016-02-16       Impact factor: 2.153

View more
  1 in total

1.  Higher EU-TIRADS-Score Correlated with BRAF V600E Positivity in the Early Stage of Papillary Thyroid Carcinoma.

Authors:  Karolina Skubisz; Joanna Januszkiewicz-Caulier; Patrycja Cybula; Elwira Bakuła-Zalewska; Krzysztof Goryca; Agnieszka Paziewska; Filip Ambrożkiewicz; Kosma Woliński; Michał Mikula; Jerzy Ostrowski; Marek Dedecjus
Journal:  J Clin Med       Date:  2021-05-25       Impact factor: 4.241

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.